日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Chimeric MHC class I- and II-restricted non-self epitopes broaden antitumor T cell reactions

嵌合的MHC I类和II类限制性非自身表位可拓宽抗肿瘤T细胞反应

Rongsheng Zhang,Rong Ma,Merrin M L Leong,Ian R Watson,Kei Iida,Tomonori Yaguchi,Fumihiko Matsuda,Tasuku Honjo,Kenji Chamoto

Tumor antigens preferentially derive from unmutated genomic sequences in melanoma and non-small cell lung cancer

黑色素瘤和非小细胞肺癌中的肿瘤抗原优先来源于未突变的基因组序列。

Anca Apavaloaei ,Qingchuan Zhao ,Leslie Hesnard ,Maxime Cahuzac ,Chantal Durette ,Jean-David Larouche ,Marie-Pierre Hardy ,Krystel Vincent ,Sylvie Brochu ,Jean-Philippe Laverdure ,Joël Lanoix ,Mathieu Courcelles ,Patrick Gendron ,Mathieu Lajoie ,Maria Virginia Ruiz Cuevas ,Eralda Kina ,Julie Perrault ,Juliette Humeau ,Grégory Ehx ,Sébastien Lemieux ,Ian R Watson ,Daniel E Speiser ,Michal Bassani-Sternberg ,Pierre Thibault ,Claude Perreault

Single-cell spatial immune landscapes of primary and metastatic brain tumours

原发性和转移性脑肿瘤的单细胞空间免疫景观

Elham Karimi #, Miranda W Yu #, Sarah M Maritan #, Lucas J M Perus #, Morteza Rezanejad, Mark Sorin, Matthew Dankner, Parvaneh Fallah, Samuel Doré, Dongmei Zuo, Benoit Fiset, Daan J Kloosterman, LeeAnn Ramsay, Yuhong Wei, Stephanie Lam, Roa Alsajjan, Ian R Watson, Gloria Roldan Urgoiti, Morag Park, 

Melanomas with concurrent BRAF non-p.V600 and NF1 loss-of-function mutations are targetable by BRAF/MEK inhibitor combination therapy

BRAF/MEK 抑制剂联合疗法可靶向治疗同时存在 BRAF 非 p.V600 和 NF1 功能丧失突变的黑色素瘤

Shivshankari Rajkumar, Diana Berry, Kayla A Heney, Colton Strong, LeeAnn Ramsay, Mathieu Lajoie, Rached Alkallas, Tan-Trieu Nguyen, Cameron Thomson, Mozhdeh Ahanfeshar-Adams, Matthew Dankner, Teresa Petrella, April A N Rose, Peter M Siegel, Ian R Watson

A nuclear cAMP microdomain suppresses tumor growth by Hippo pathway inactivation

核 cAMP 微区通过 Hippo 通路失活抑制肿瘤生长

Marek M Drozdz, Ashley S Doane, Rached Alkallas, Garrett Desman, Rohan Bareja, Michael Reilly, Jakyung Bang, Maftuna Yusupova, Jaewon You, Zuhal Eraslan, Jenny Z Wang, Akanksha Verma, Kelsey Aguirre, Elsbeth Kane, Ian R Watson, Olivier Elemento, Elena Piskounova, Taha Merghoub, Jonathan H Zippin

Neutrophil oxidative stress mediates obesity-associated vascular dysfunction and metastatic transmigration

中性粒细胞氧化应激介导肥胖相关的血管功能障碍和转移性迁移

Sheri A C McDowell, Robin B E Luo, Azadeh Arabzadeh, Samuel Doré, Nicolas C Bennett, Valérie Breton, Elham Karimi, Morteza Rezanejad, Ryan R Yang, Katherine D Lach, Marianne S M Issac, Bozena Samborska, Lucas J M Perus, Dan Moldoveanu, Yuhong Wei, Benoit Fiset, Roni F Rayes, Ian R Watson, Lawrence K

Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase Inhibition

核苷酸代谢重编程介导表观遗传治疗与 MAP 激酶抑制之间的协同作用

Tatiana Shorstova, Jie Su, Tiejun Zhao, Michael Dahabieh, Matthew Leibovitch, Mariana De Sa Tavares Russo, Daina Avizonis, Shivshankari Rajkumar, Ian R Watson, Sonia V Del Rincón, Wilson H Miller Jr, William D Foulkes, Michael Witcher

C3a elicits unique migratory responses in immature low-density neutrophils

C3a 在未成熟低密度中性粒细胞中引发独特的迁移反应

Brian E Hsu, Joannie Roy, Jack Mouhanna, Roni F Rayes, LeeAnn Ramsay, Sébastien Tabariès, Matthew G Annis, Ian R Watson, Jonathan D Spicer, Santiago Costantino, Peter M Siegel

MAPK Pathway Inhibitors Sensitize BRAF-Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB

MAPK 通路抑制剂使 BRAF 突变型黑色素瘤对靶向 GPNMB 的抗体-药物偶联物敏感

April A N Rose, Matthew G Annis, Dennie T Frederick, Marco Biondini, Zhifeng Dong, Lawrence Kwong, Lynda Chin, Tibor Keler, Thomas Hawthorne, Ian R Watson, Keith T Flaherty, Peter M Siegel

Human platelet activation by Escherichia coli: roles for FcγRIIA and integrin αIIbβ3

大肠杆菌激活人血小板:FcγRIIA 和整合素 αIIbβ3 的作用

Watson, Callum N; Kerrigan, Steven W; Cox, Dermot; Henderson, Ian R; Watson, Steve P; Arman, Mònica